Rothschild Investment LLC’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17K Buy
275
+180
+189% +$2.91K ﹤0.01% 2521
2025
Q4
$1.63K Buy
95
+86
+956% +$1.67K ﹤0.01% 2471
2025
Q3
$237 Sell
9
-17
-65% -$642 ﹤0.01% 2986
2025
Q2
$1.52K Hold
26
﹤0.01% 2238
2025
Q1
$2.77K Buy
26
+16
+160% +$1.39K ﹤0.01% 1710
2024
Q4
$456 Buy
10
+4
+67% +$242 ﹤0.01% 2571
2024
Q3
$609 Buy
6
+4
+200% +$517 ﹤0.01% 2410
2024
Q2
$262 Buy
+2
New +$285 ﹤0.01% 2368

Other funds holding AGL

Rothschild Investment LLC's AGL Position: Q1 2026 in Review

Rothschild Investment LLC increased its Agilon Health (AGL) stake by 189% in Q1 2026, buying an estimated $2.91K and bringing the position to 275 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Rothschild Investment LLC first reported a position in AGL in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.77K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Rothschild Investment LLC held 275 shares of Agilon Health worth $2.17K as of Q1 2026.
  • Rothschild Investment LLC bought 180 Agilon Health shares in Q1 2026, an estimated $2.91K.
  • Agilon Health made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2521 holding.
  • Rothschild Investment LLC first reported a position in Agilon Health in Q2 2024 and has held it in 8 quarters since.
  • Rothschild Investment LLC's Agilon Health position peaked at $2.77K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.